YoVDO

ctDNA for Minimal Disease Research by Hybridization Capture in Resected Cancer Samples

Offered By: Integrated DNA Technologies (IDT) via YouTube

Tags

Cancer Research Courses Genomics Courses Oncology Courses Biomarkers Courses Liquid Biopsies Courses

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Explore how hybridization capture solutions are revolutionizing circulating tumor DNA (ctDNA) research for minimal residual disease (MRD) in this 17-minute webinar by Integrated DNA Technologies (IDT). Gain valuable insights into the significance of MRD research, its advantages over traditional methods, and its role in discovering new biomarkers. Understand how IDT's technology is helping researchers overcome challenges in ctDNA analysis for resected cancer samples. Discover the potential for new collaborations and breakthroughs in oncology research as these innovative studies are brought to the forefront. For more information, visit https://idtb.io/bmru7r.

Syllabus

ctDNA for minimal disease research by hybridization capture in resected cancer samples


Taught by

Integrated DNA Technologies (IDT)

Related Courses

El abordaje multidisciplinar de las demencias
Universidad de Cantabria via Miríadax
Demystifying Targeted Cancer Treatments
Cancer Research UK via FutureLearn
Diagnosis and prognosis biomarkers in global health
Institut Pasteur via France Université Numerique
Extracellular Vesicles in Health and Disease
University of California, Irvine via Coursera
Procalcitonin: PCT as a Biomarker for Antimicrobial Stewardship
The British Society for Antimicrobial Chemotherapy via FutureLearn